Construction of Drug Network Based on Side Effects and Its Application for Drug Repositioning
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Construction of Drug Network Based on Side Effects and Its Application for Drug Repositioning
Authors
Keywords
-
Journal
PLoS One
Volume 9, Issue 2, Pages e87864
Publisher
Public Library of Science (PLoS)
Online
2014-02-05
DOI
10.1371/journal.pone.0087864
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Predicting Targeted Polypharmacology for Drug Repositioning and Multi- Target Drug Discovery
- (2013) X. Liu et al. CURRENT MEDICINAL CHEMISTRY
- Network-based drug repositioning
- (2013) Zikai Wu et al. Molecular BioSystems
- Drug Repurposing: Far Beyond New Targets for Old Drugs
- (2012) T. I. Oprea et al. AAPS Journal
- A pathway profile-based method for drug repositioning
- (2012) Hao Ye et al. CHINESE SCIENCE BULLETIN
- Predicting New Indications for Approved Drugs Using a Proteochemometric Method
- (2012) Sivanesan Dakshanamurthy et al. JOURNAL OF MEDICINAL CHEMISTRY
- Prediction of chemical–protein interactions: multitarget-QSAR versus computational chemogenomic methods
- (2012) Feixiong Cheng et al. Molecular BioSystems
- Use of genome-wide association studies for drug repositioning
- (2012) Philippe Sanseau et al. NATURE BIOTECHNOLOGY
- Outlook for the next 5 years in drug innovation
- (2012) Roy Berggren et al. NATURE REVIEWS DRUG DISCOVERY
- Recycling side-effects into clinical markers for drug repositioning
- (2012) Miquel Duran-Frigola et al. Genome Medicine
- Study of drug function based on similarity of pathway fingerprint
- (2012) Hao Ye et al. Protein & Cell
- PREDICT: a method for inferring novel drug indications with application to personalized medicine
- (2011) A. Gottlieb et al. Molecular Systems Biology
- The productivity crisis in pharmaceutical R&D
- (2011) Fabio Pammolli et al. NATURE REVIEWS DRUG DISCOVERY
- DRAR-CPI: a server for identifying drug repositioning potential and adverse drug reactions via the chemical–protein interactome
- (2011) Heng Luo et al. NUCLEIC ACIDS RESEARCH
- Systematic Drug Repositioning Based on Clinical Side-Effects
- (2011) Lun Yang et al. PLoS One
- Effect of catechol-O-methyltransferase Val(108/158)Met polymorphism on antidepressant efficacy of fluvoxamine
- (2010) F. Benedetti et al. EUROPEAN PSYCHIATRY
- An investigation of EEG, genetic and cognitive markers of treatment response to antidepressant medication in patients with major depressive disorder: A pilot study
- (2010) D. Spronk et al. JOURNAL OF AFFECTIVE DISORDERS
- The functional Val158Met polymorphism in catechol-O-methyltransferase (COMT) is associated with depression and motivation in men from a Swedish population-based study
- (2010) Elin Åberg et al. JOURNAL OF AFFECTIVE DISORDERS
- A side effect resource to capture phenotypic effects of drugs
- (2010) Michael Kuhn et al. Molecular Systems Biology
- Discovery of drug mode of action and drug repositioning from transcriptional responses
- (2010) F. Iorio et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tolcapone: review of its pharmacology and use as adjunctive therapy in patients with Parkinson's disease
- (2010) Daniel Truong Clinical Interventions in Aging
- Opiates as Antidepressants
- (2009) Esther Berrocoso et al. CURRENT PHARMACEUTICAL DESIGN
- Evaluation of antidepressant activity of tramadol in mice
- (2009) BhupinderSingh Kalra et al. INDIAN JOURNAL OF PHARMACOLOGY
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
- (2009) Da Wei Huang et al. Nature Protocols
- Pharmaceutical R&D: the road to positive returns
- (2009) Eric David et al. NATURE REVIEWS DRUG DISCOVERY
- The catechol-O-methyltransferase Val(108/158)Met polymorphism affects antidepressant response to paroxetine in a naturalistic setting
- (2008) Francesco Benedetti et al. PSYCHOPHARMACOLOGY
- Influence of the tyrosine hydroxylase val81met polymorphism and catechol-O-methyltransferase val158met polymorphism on the antidepressant effect of milnacipran
- (2007) Keizo Yoshida et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started